Armune BioScience Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Armune BioScience Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7314
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥34,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥69,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥103,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Armune BioScience Inc (Armune BioScience), a subsidiary of Exact Sciences Corp is a medical device development company that develops and commercializes molecular prognostic and diagnostic tests. The company uses genomics and proteomics in cancer to identifying specific sets of genes or proteins. It develops protein signature based diagnostic tests for lung, prostate, and breast cancers that helps the physicians to differentiate between indolent and aggressive prostate cancer. Armune BioScience has also developed a phage protein microarray method to characterize autoantibody in cancer. The company is developing a prostate cancer diagnostic blood test having high sensitivity and specificity. It operates a research laboratory is located in Ann Arbor. Armune BioScience is headquartered in Kalamazoo, Michigan, the US.

Armune BioScience Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Armune BioScience Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Armune BioScience Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Armune BioScience Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Armune BioScience Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Armune BioScience Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Armune BioScience Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Armune BioScience Raises USD0.5 Million in Venture Financing 10
Armune BioScience Raises USD5 Million in Series A Venture Financing 11
Armune BioScience Raises USD4 Million in Second and Final Tranche of Series A Financing 12
Armune BioScience to Raise USD25 Million in Series B Financing 13
Armune BioScience Raises Additional USD5.6 Million in Venture Financing 14
Armune Biosciences Raises USD2.5 Million in Series A Venture Financing 15
Armune BioScience Raises USD3.5 Million in Venture Financing 16
Armune BioScience Raises US$1.4 Million In Venture Financing 17
Partnerships 18
Aeterna Zentaris Expands its Co-Marketing Agreement with Armune BioScience 18
Acquisition 19
Exact Sciences Acquires Armune Bioscience 19
Armune BioScience Inc – Key Competitors 20
Armune BioScience Inc – Key Employees 21
Armune BioScience Inc – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Armune BioScience Inc, Medical Equipment, Key Facts 2
Armune BioScience Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Armune BioScience Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Armune BioScience Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Armune BioScience Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Armune BioScience Inc, Deals By Market, 2012 to YTD 2018 8
Armune BioScience Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Armune BioScience Raises USD0.5 Million in Venture Financing 10
Armune BioScience Raises USD5 Million in Series A Venture Financing 11
Armune BioScience Raises USD4 Million in Second and Final Tranche of Series A Financing 12
Armune BioScience to Raise USD25 Million in Series B Financing 13
Armune BioScience Raises Additional USD5.6 Million in Venture Financing 14
Armune Biosciences Raises USD2.5 Million in Series A Venture Financing 15
Armune BioScience Raises USD3.5 Million in Venture Financing 16
Armune BioScience Raises US$1.4 Million In Venture Financing 17
Aeterna Zentaris Expands its Co-Marketing Agreement with Armune BioScience 18
Exact Sciences Acquires Armune Bioscience 19
Armune BioScience Inc, Key Competitors 20
Armune BioScience Inc, Key Employees 21
Armune BioScience Inc, Other Locations 22

List of Figures
Armune BioScience Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Armune BioScience Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Armune BioScience Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Armune BioScience Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Armune BioScience Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Armune BioScience Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Armune BioScience Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Armune BioScience Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Armune BioScience Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Bharat Dynamics Limited
    Bharat Dynamics Limited - Strategy, SWOT and Corporate Finance Report Summary Bharat Dynamics Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Austin Industries, Inc.:企業の戦略・SWOT・財務情報
    Austin Industries, Inc. - Strategy, SWOT and Corporate Finance Report Summary Austin Industries, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • PT Pudjiadi Prestige Tbk:企業の戦略・SWOT・財務情報
    PT Pudjiadi Prestige Tbk - Strategy, SWOT and Corporate Finance Report Summary PT Pudjiadi Prestige Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • LIXIL Group Corporation:企業の戦略・SWOT・財務分析
    LIXIL Group Corporation - Strategy, SWOT and Corporate Finance Report Summary LIXIL Group Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • U.S. Preventive Medicine Inc-製薬・医療分野:企業M&A・提携分析
    Summary U.S. Preventive Medicine Inc (USPM) is a healthcare service center that provides wellness and care management services. The center offers preventive plan, a web-based or online health management platform for the clinical science of preventive medicine. Its preventive plan library provides in …
  • Keikyu Corporation:企業の戦略・SWOT・財務情報
    Keikyu Corporation - Strategy, SWOT and Corporate Finance Report Summary Keikyu Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Poxel SA (POXEL):企業の財務・戦略的SWOT分析
    Summary Poxel SA (Poxel) is a biopharmaceutical company that focuses to develop drugs for metabolic diseases. The company’s pipeline product portfolio includes Imeglimin, which is developed to target mitochondrial dysfunction, for the treatment of type 2 diabetes; PXL065, a mitochondrial pyruvate ca …
  • CME Group Inc.:戦略・SWOT・企業財務分析
    CME Group Inc. - Strategy, SWOT and Corporate Finance Report Summary CME Group Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Singulus Technologies AG (SNG):企業の財務・戦略的SWOT分析
    Summary Singulus Technologies AG (Singulus Technologies) is an optical disc production line manufacturer that develops technologies for efficient and resource-conserving production processes. The company offers optical disc solutions such as blu-ray disc, CD, and DVD production equipment. Its solar …
  • Petromin Resources Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Petromin Resources Ltd (Petromin) is an oil and gas exploration and production company that acquires, explores, develops and produces petroleum and natural gas. The company’s projects include Gilby, Redwater, Frog Lake and MorningSide projects in Alberta, Canada. It also explores and develop …
  • ION Geophysical Corp (IO):企業の財務・戦略的SWOT分析
    ION Geophysical Corp (IO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Cara Therapeutics Inc (CARA):医療機器:M&Aディール及び事業提携情報
    Summary Cara Therapeutics Inc (Cara Therapeutics) is a biotechnology company that develops and commercializes chemical entities for acutepain, chronic pain and pruritus. The company offers kappa opioid receptor agonists in the therapeutic areas of acute pain, chronic pain, neuropathic pain and pruri …
  • Evoqua Water Technologies Corp (AQUA):企業の財務・戦略的SWOT分析
    Evoqua Water Technologies Corp (AQUA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • RISE Life Science Corp:企業のM&A・事業提携・投資動向
    RISE Life Science Corp - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's RISE Life Science Corp Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Autoridad del Canal de Panama:企業の戦略的SWOT分析
    Autoridad del Canal de Panama - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Adimab LLC-製薬・医療分野:企業M&A・提携分析
    Summary Adimab LLC (Adimab) is an antibody discovery technology provider that offers antibody discovery and optimization platform. The company discovers antibodies for a range of disease areas including oncology, immunomodulation, neuroscience and pain, inflammation, cardiovascular and metabolic dis …
  • Lycored Ltd:企業の戦略・SWOT・財務情報
    Lycored Ltd - Strategy, SWOT and Corporate Finance Report Summary Lycored Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Strata-X Energy Ltd (SXE):石油・ガス:M&Aディール及び事業提携情報
    Summary Strata-X Energy Ltd (Strata-X Energy), formerly Strata-X Ltd, is an independent oil and gas exploration company. The company operates in the acquisition, exploration and development of oil and gas properties in the US states of California and Illinois and in the Republic of Botswana. It prov …
  • Sumitomo Mitsui Construction Co Ltd (1821):企業の財務・戦略的SWOT分析
    Sumitomo Mitsui Construction Co Ltd (1821) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • Culture Landmark Investment Ltd:企業の戦略・SWOT・財務分析
    Culture Landmark Investment Ltd - Strategy, SWOT and Corporate Finance Report Summary Culture Landmark Investment Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆